BMB Seminars: Fall 2018/Spring 2019
Seminars will be held in EC 1218 unless noted 

Date

Speaker

 
September 28 Kebin Liu, PhD
Professor, AU Department of Biochemistry and Molecular Biology
Title:  Role of Suv39h1 in CTL effector function and tumor immune evasion
 

 

November 2 Philip Buckhaults, PhD
Associate Professor, University of South Carolina
Exploiting TP53 mutations for cancer therapeutics

 

November 30  Rudolf Lucas, PhD
Professor, Dept. of Pharmacology/Toxicology, Augusta Univeristy
Tumor Necrosis Factor: a two-edged sword in the lungs

 
January 18 Daitoku Sakamuro, PhD
Associate Professor, Dept. of Biochemistry and Molecular Biology, AU
How does PARP inhibition activate anoikis, a trait of normal epithelium, in cancer cells?

 

February 1 Honglin Li, PhD
Associate Professor, Dept. of Biochemistry and Molecular Biology, AU
Ufmylation of ribosomal protein uL24 (RPL26) and its potential role in ribosome-associated protein quality control

 

 February 8 Nagendra Singh, PhD
Associate Professor, Dept. of Biochemistry and Molecular Biology, AU
Ufbp1 unfolds the unfolded protein response of plasma cells and multiple myelomas
 
February 22 Muthusamy Thangaraju, PhD
Associate Professor, Dept. of Biochemistry and Molecular Biology, AU
RAD51AP1, a novel therapeutic target for breast cancer treatment
 
March 1 Erik Knudsen, PhD
Chair, Molecular and Cell Biology, Roswell Park Comprehensive Cancer Center
Divide and Conquer: Targeting Cell Cycle in Cancer Therapy
 
March 15 Thomas Weimbs, PhD  
March 22 Leonidas Tsiokas, PhD  
April 5 Jan van Riggelen, PhD  
April 19 Linda Hendershot, PhD  
April 26 Yan Dong, PhD